| SUBSCRIPTIONS |
|
|
|
DTCNews Subscription
|
|
|
 |
|
| We accept |
|
 |
|
 |
|
| Vacacionar Travel S.A. use Credit du Nord as a guarantee of absolute security in credit card transactions. |
|
 |
|
 |
|
|
|
|
|
|
 |
:
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
Program to Treat Ataxia Patients Evaluated |
|
|
Monday, March 30, 2015
Havana.- Cuban experts are carrying out a clinical trial to improve the therapeutic options to treat patients suffering from spinocerebellar ataxia type 2 (SCA2).
The evaluations include the neuro-protective effect of human recombinant erythropoietin (Neuro-EPO), which is produced at the Molecular Immunology Center.
The medicine is a hormone produced naturally by the body and has a neuro-protective function.
Therefore, it is essential in the treatment of neuro-inflammatory and neuro-degenerative diseases, as well as in the treatment of ischemic damage and brain traumas.
More than 30 patients were chosen for the clinical trial. They underwent clinical, neuro-physiological and hemo-chemical tests.
|
|
|
|
|
|
|
|
|
|